EORTC-NCI-AACR--14th Symposium.  Molecular targets and cancer therapeutics--part I.  19-22 November 2002, Frankfurt, Germany.
Patterson
Clare
C
Thomson Current Drugs, Middlesex House, 34-42 Cleveland Street, London W1T 4LB, UK. clare.patterson@current-drugs.com
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*
D020533:Angiogenesis Inhibitors; D018906:Antineoplastic Agents, Alkylating; D004815:Epidermal Growth Factor